PETALING JAYA: Pharmaniaga Bhd
will focus on targeted initiatives aimed at streamlining business activities to exit its Practice Note 17 (PN17) status.
In a statement, executive committee chairman Ahmad Shahredzuan Mohd Shariff said the pharmaceutical company will optimise its overall business operations and costs, as well as finding synergies across all of its business units.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
